Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $404,097 | 132 | 80.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,770 | 9 | 6.1% |
| Honoraria | $24,710 | 6 | 4.9% |
| Travel and Lodging | $24,098 | 89 | 4.8% |
| Education | $9,259 | 8 | 1.8% |
| Food and Beverage | $5,828 | 123 | 1.2% |
| Unspecified | $5,638 | 2 | 1.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Braintree Laboratories, Inc. | $90,000 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $61,350 | 66 | $0 (2024) |
| PFIZER INC. | $55,619 | 39 | $0 (2024) |
| Eli Lilly and Company | $42,800 | 17 | $0 (2024) |
| ABBVIE INC. | $30,972 | 23 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $30,684 | 26 | $0 (2018) |
| GlaxoSmithKline, LLC. | $26,409 | 15 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $24,883 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $18,625 | 6 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $18,216 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73,102 | 62 | Janssen Biotech, Inc. ($17,222) |
| 2023 | $73,154 | 64 | Janssen Scientific Affairs, LLC ($11,598) |
| 2022 | $44,085 | 30 | E.R. Squibb & Sons, L.L.C. ($7,360) |
| 2021 | $64,898 | 22 | AbbVie Inc. ($27,884) |
| 2020 | $62,432 | 28 | Braintree Laboratories, Inc. ($15,000) |
| 2019 | $51,511 | 38 | Braintree Laboratories, Inc. ($17,500) |
| 2018 | $74,094 | 66 | Merck Sharp & Dohme Corporation ($20,499) |
| 2017 | $61,123 | 59 | Braintree Laboratories, Inc. ($20,000) |
All Payment Transactions
369 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: Immunology | ||||||
| 12/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $38.42 | General |
| Category: Immunology | ||||||
| 08/20/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| 08/07/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| 06/28/2024 | PFIZER INC. | VELSIPITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 06/12/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| 05/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: Immunology | ||||||
| 05/22/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 05/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $146.28 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 04/25/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 04/15/2024 | Hexal AG | — | Consulting Fee | Cash or cash equivalent | $3,510.00 | General |
| 04/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Consulting Fee | Cash or cash equivalent | $9,375.00 | General |
| 04/10/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 04/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 03/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $23.80 | General |
| Category: Immunology | ||||||
| 03/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $42.49 | General |
| 03/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $29.75 | General |
| 03/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $21.16 | General |
| 03/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $12.74 | General |
| 03/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Travel and Lodging | In-kind items and services | $514.20 | General |
| 03/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Travel and Lodging | In-kind items and services | $292.67 | General |
| 03/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Travel and Lodging | In-kind items and services | $96.59 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
| A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease | E.R. Squibb & Sons, L.L.C. | $2,438 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 280 | 324 | $281,551 | $35,463 |
| 2022 | 7 | 237 | 262 | $248,259 | $30,245 |
| 2021 | 9 | 273 | 282 | $62,859 | $30,256 |
| 2020 | 9 | 353 | 373 | $80,669 | $35,294 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 145 | $65,250 | $13,007 | 19.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 72 | 74 | $127,736 | $10,219 | 8.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $24,745 | $4,008 | 16.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $40,504 | $3,337 | 8.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $14,256 | $2,746 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $9,060 | $2,145 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 107 | $48,150 | $10,056 | 20.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 58 | 59 | $105,728 | $7,299 | 6.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $18,711 | $3,700 | 19.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 13 | 14 | $28,266 | $2,920 | 10.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $12,726 | $2,336 | 18.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 28 | 30 | $26,826 | $2,208 | 8.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $7,852 | $1,726 | 22.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 77 | 78 | $25,966 | $9,798 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 57 | $8,034 | $5,188 | 64.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $7,152 | $5,152 | 72.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 26 | $5,140 | $3,515 | 68.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 16 | 16 | $7,163 | $2,952 | 41.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 24 | 24 | $5,307 | $1,809 | 34.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $2,536 | $1,488 | 58.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 12 | $266.16 | $261.72 | 98.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 22 | 22 | $1,295 | $92.80 | 7.2% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 71 | 71 | $28,361 | $9,351 | 33.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 59 | 59 | $12,417 | $8,908 | 71.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 67 | $9,256 | $5,108 | 55.2% |
About Dr. Francis Farraye, M.D
Dr. Francis Farraye, M.D is a Internal Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427035286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Farraye, M.D has received a total of $504,399 in payments from pharmaceutical and medical device companies, with $73,102 received in 2024. These payments were reported across 369 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($404,097).
As a Medicare-enrolled provider, Farraye has provided services to 1,143 Medicare beneficiaries, totaling 1,241 services with total Medicare billing of $131,258. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Jacksonville, FL
- Active Since 12/22/2005
- Last Updated 08/31/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427035286
Products in Payments
- SUPREP BOWEL PREP (Drug) $55,000
- STELARA (Biological) $53,611
- SUPREP (Drug) $35,000
- XELJANZ (Drug) $34,600
- TREMFYA (Drug) $19,772
- MONOFERRIC (Drug) $17,110
- SIMPONI (Biological) $15,074
- Entyvio (Biological) $14,911
- ZEPOSIA (Drug) $9,410
- SHINGRIX (Biological) $8,748
- PREPOPIK (Drug) $8,088
- CLENPIQ (Drug) $6,420
- INFLECTRA (Biological) $5,679
- REMICADE (Biological) $5,665
- VELSIPITY (Drug) $4,500
- Sotyktu (Drug) $1,681
- Mytesi (Drug) $1,580
- HUMIRA (Biological) $650.00
- IDACIO (Biological) $610.00
- Humira (Biological) $177.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jacksonville
Siddharth Wayangankar, Md, MD
Internal Medicine — Payments: $1.3M
Dr. Alan Miller, M.d, M.D
Internal Medicine — Payments: $770,575
Kalina Sanders, M.d, M.D
Internal Medicine — Payments: $626,907
Jose Soto Soto, Md, MD
Internal Medicine — Payments: $576,809
Dr. Jennifer Fulton, Md, MD
Internal Medicine — Payments: $556,016
Dr. Eddy Gutierrez, Md, MD
Internal Medicine — Payments: $296,024